CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

As Americans struggle to afford groceries and utilities, a new study finds that three Ohio cities are among the most ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

The personal finance company WalletHub issued its latest survey of cities where people spend the most and least on health ...

Abbreviated new drug application filings have declined to 600 in the financial year 2025 (ending in September) versus 740 in ...

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

Accord is pleased to announce the appointment of Paul Burden as Associate Vice President and Country Head of Accord UK, effective immediately.

Nutex Health Inc. ("Nutex Health" or the "Company") , a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro hospitals and hospital outpatient departments in 12 ...

There's a reason "health" and "wealth" rhyme. They may be the same thing. The personal finance company WalletHub issued its ...

With the New Year comes new laws that will go into effect in California. Nearly 800 bills were passed by the state legislature and signed by the governor in 2025, ...